Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

Market Cap	15.84B -27.3%
Revenue (ttm)	417.21M -0.4%
Net Income	-215.28M
EPS	-1.35
Shares Out	159.27M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,335,474
Open	95.77
Previous Close	100.65
Day's Range	95.77 - 103.98
52-Week Range	79.00 - 188.93
Beta	1.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. It also provides technical services such as drug development, including the development and quality research of active pharmaceutical ingredients (APIs) and formulation processes. Fujian Cosunter Pharmaceutical Co., Ltd. was founde...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 715
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300436

Financial Performance

In 2025, SHE:300436's revenue was 416.37 million, a decrease of -5.68% compared to the previous year's 441.46 million. Losses were -217.85 million, 39.4% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 14, 2026

Data Sources Report a data error